411 – 420 of 2053
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
The impact of ademetionine and ipidacrine/phenibut on the NCAM distribution and behavior in the rat model of drug-induced liver injury
(
- Contribution to journal › Article
- 2019
-
Mark
An evaluation of zonisamide, including its long-term efficacy, for the treatment of focal epilepsy
(
- Contribution to journal › Article
-
Mark
The effect of locally delivered cisplatin is dependent on an intact immune function in an experimental glioma model
(
- Contribution to journal › Article
-
Mark
Cangrelor for ST-Segment-Elevation Myocardial Infarction
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
An orally active galectin-3 antagonist inhibits lung adenocarcinoma growth and augments response to PD-L1 blockade
(
- Contribution to journal › Article
-
Mark
RIFM fragrance ingredient safety assessment, 1-cyclohexene-1-acetic acid, CAS Registry Number 18294-87-6
(
- Contribution to journal › Scientific review
-
Mark
Rapamycin – “One size does not fit all”
2019) In EBioMedicine(
- Contribution to journal › Debate/Note/Editorial
-
Mark
What is understood by “animal-free research”?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
RIFM fragrance ingredient safety assessment, 2-octanone, CAS Registry Number 111-13-7
(
- Contribution to journal › Article
-
Mark
RIFM fragrance ingredient safety assessment, 3,7-dimethyl-6-octenoic acid, CAS Registry Number 502-47-6
(
- Contribution to journal › Article